You searched for Humanized antibody - Page 3 of 44

adc therapeutics antibody drug conjugates

News and Trends 9 Jul 2019

Update: Swiss Biotech’s Series E Expanded to €271M to Commercialize Antibody-Guided Cancer Chemotherapy

…of Hodgkin’s lymphoma. ADC Therapeutics’ treatment is an antibody molecule attached to a toxic drug ‘warhead’, also known as an antibody-drug conjugate. The drug is designed to treat diffuse large…

July 9, 2019 - 3 minutesmins - By Jonathan Smith

In Depth 9 Aug 2023

Meet the startup working to help treat a rare pediatric cancer

…therapy and stem cell transplantation. The only humanized anti-GD2 monoclonal antibody in the market at present, is American biotech Y-mAbs Therapeutics’ Danyelza, which is prescribed only in cases of refractory…

August 9, 2023 - 7 minutesmins - By Roohi Mariam Peter

CatalYm’s monoclonal antibody visugromab bags $150M

News and Trends 16 Jul 2024

German biotech raises $150M on its way to tackle cancer therapy resistance

…Gilde Healthcare. CatalYm is a Munich-based biotech company, with a novel approach to tackle cancer resistance through its lead candidate, visugromab. This humanized monoclonal antibody targets the tumor-produced growth differentiation…

July 16, 2024 - 9 minutesmins - By Jules Adam

In Depth 15 Feb 2024

Turning the tide: recent advancements in childhood cancer research

…the formation of a tumor. As neuroblastomas predominantly express the molecule GD2, Renaissance’s lead candidate Hu14.18 is a humanized, anti-GD2 antibody. When an anti-GD2 antibody is combined with chemotherapy in…

February 15, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 27 Jun 2023

UCB myasthenia gravis drug given FDA approval

…receptor (AchR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive. Rozanolixizumab-noli injection for subcutaneous infusion is a humanized IgG4 monoclonal antibody that binds to the neonatal Fc receptor (FcRN), resulting in…

June 27, 2023 - 5 minutesmins - By Jim Cornall

News and Trends 18 May 2017

Spanish Biotech Clears €2.7M Funding Round for its New Stroke Drug

…comes in addition to Biogen’s Phase II antibody Natalizumab that blocks the recruitment of inflammatory cells. Similar to AptaTarget, French Acticor Biotech just raised €1.5M for its humanized antibody fragment…

May 18, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 20 Jul 2023

Mage Biologics created to develop oral antibody therapy for ulcerative colitis

…(PFC) investment for TVM LSI II. Mage Biologics plans to advance to clinical proof of concept a novel, orally administered, humanized monoclonal antibody (mAb) bioengineered for optimal potency and tissue…

July 20, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 18 Jul 2022

Trial for drug targeting cancerous tumors begins in China

…novel IgG4-type humanized anti-CD47 monoclonal antibody was given to the first patient as part of the multicenter, open-label study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy for the…

July 18, 2022 - 3 minutesmins - By Liza Laws

In Depth 26 Jul 2023

Antibody drug conjugates: BiVictriX drives a new era in cancer medicine

…a monoclonal antibody – which binds to the cancer protein in a cell – attached to a linker, which delivers the anticancer drug once the antibody latches on to the…

July 26, 2023 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 24 Feb 2020

Meet 20 European Immuno-Oncology Companies that are Fighting Cancer

…very few European biotechs valued at over €1B. MorphoSys develops antibody therapies for numerous conditions. The company’s lead immuno-oncology candidate tafasitamab is a humanized monoclonal antibody that targets CD19, an…

February 24, 2020 - 12 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 21 Nov 2016

One Antibody to Neutralize 98% of All HIV Strains: Closer to a Cure?

…a research article in Cell Immunity reported a detailed study of an antibody that could neutralize 98% of HIV strains. The N6 antibody can also target 16 of the 20…

November 21, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Harnessing antibody-drug conjugates (ADCs) in oncology: Pathways to clinical success

…for HER2+ metastatic breast cancer,” said Dr Barnett. “It was built on an antibody already being used so there was familiarity. The tumors that responded to that antibody were recognized…

November 26, 2024 - 8 minutesmins - By Will Chu

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Update: Swiss Biotech’s Series E Expanded to €271M to Commercialize Antibody-Guided Cancer Chemotherapy

Meet the startup working to help treat a rare pediatric cancer

German biotech raises $150M on its way to tackle cancer therapy resistance

Turning the tide: recent advancements in childhood cancer research

UCB myasthenia gravis drug given FDA approval

Spanish Biotech Clears €2.7M Funding Round for its New Stroke Drug

Mage Biologics created to develop oral antibody therapy for ulcerative colitis

Trial for drug targeting cancerous tumors begins in China

Antibody drug conjugates: BiVictriX drives a new era in cancer medicine

Meet 20 European Immuno-Oncology Companies that are Fighting Cancer

One Antibody to Neutralize 98% of All HIV Strains: Closer to a Cure?

Harnessing antibody-drug conjugates (ADCs) in oncology: Pathways to clinical success

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!